1-3 of 3
Wilhelm Wössmann
Close
Sort by
Journal Articles

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Brief Report
Rabea Wagener, Cristina López, Kortine Kleinheinz, Julia Bausinger, Sietse M. Aukema, Inga Nagel, Umut H. Toprak, Julian Seufert, Janine Altmüller, Holger Thiele, Christof Schneider, Julia Kolarova, Jeongbin Park, Daniel Hübschmann, Eva M. Murga Penas, Hans G. Drexler, Andishe Attarbaschi, Randi Hovland, Eigil Kjeldsen, Michael Kneba, Udo Kontny, Laurence de Leval, Peter Nürnberg, Ilske Oschlies, David Oscier, Brigitte Schlegelberger, Stephan Stilgenbauer, Wilhelm Wössmann, Matthias Schlesner, Birgit Burkhardt, Wolfram Klapper, Elaine S. Jaffe, Ralf Küppers, Reiner Siebert
Journal: Blood
Blood (2018) 132 (21): 2280–2285.
https://doi.org/10.1182/blood-2018-03-842088
Published: 2018
Includes: Supplemental data
Journal Articles

Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas

Nora Naumann-Bartsch, MD, Daniel Stachel, MD, Martin Chada, MD, Torsten Fritscher, MD, Oliver Rompel, MD, Florian Haller, MD, Arndt Hartmann, MD, Wilhelm Wößmann, MD, Markus Metzler, MD
Journal: Blood
Blood (2016) 128 (22): 5414.
https://doi.org/10.1182/blood.V128.22.5414.5414
Published: 2016
Journal Articles

Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma

Brief Report
Andishe Attarbaschi, Georg Mann, Angelo Rosolen, Denise Williams, Anne Uyttebroeck, Ildiko Marky, Laurence Lamant, Keizo Horibe, Grazyna Wrobel, Auke Beishuizen, Wilhelm Wössmann, Alfred Reiter, Audrey Mauguen, Marie-Cecile Le Deley, Laurence Brugières, for the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) ALCL99 Trial
Journal: Blood
Blood (2011) 117 (21): 5616–5619.
https://doi.org/10.1182/blood-2010-12-324012
Published: 2011